Heuser, M., Smith, B. D., Fiedler, W., Sekeres, M. A., Montesinos, P., Leber, B., . . . Cortes, J. E. (2021). Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: Long-term analysis of a phase II randomized trial. Ann Hematol.
শিকাগো স্টাইলে সাইটেশনHeuser, Michael, et al. "Clinical Benefit of Glasdegib Plus Low-dose Cytarabine in Patients With De Novo and Secondary Acute Myeloid Leukemia: Long-term Analysis of a Phase II Randomized Trial." Ann Hematol 2021.
এমএলএ সাইটেশনHeuser, Michael, et al. "Clinical Benefit of Glasdegib Plus Low-dose Cytarabine in Patients With De Novo and Secondary Acute Myeloid Leukemia: Long-term Analysis of a Phase II Randomized Trial." Ann Hematol 2021.